Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis
S. Sangès, Lisa Rice, Ly Tu, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 3, pp. 365-373
Open Access | Times Cited: 22

Showing 22 citing articles:

Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review
Bianca Saveria Fioretto, Irene Rosa, Marco Matucci‐Cerinic, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4097-4097
Open Access | Times Cited: 16
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again
Milan Bahi, Christine Li, G.C. Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4728-4728
Open Access | Times Cited: 5
The Dual Role of Chemerin in Lung Diseases
Philomène Lavis, Benjamin Bondue, Alessandra K. Cardozo
Cells (2024) Vol. 13, Iss. 2, pp. 171-171
Open Access | Times Cited: 3
Protein profiling in systemic sclerosis patients with different pulmonary complications using proteomic antibody microarray
Jing Huang, Honglin Zhu, Sijia Liu, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 3
Single cell analysis in systemic sclerosis – A systematic review
Takemichi Fukasawa, Asako Yoshizaki‐Ogawa, Atsushi Enomoto, et al.
Immunological Medicine (2024) Vol. 47, Iss. 3, pp. 118-129
Open Access | Times Cited: 3
Interleukin-17A is a potential therapeutic target predicted by proteomics for systemic sclerosis patients at high risk of pulmonary arterial hypertension
Yūichi Ono, Akira Mogami, Ryuta Saito, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Beatrice Moccaldi, Laura De Michieli, Marco Binda, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4178-4178
Open Access | Times Cited: 8
Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension
Valentine Mismetti, Xavier Delavenne, David Montani, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis
Francesca Motta, Antonio Tonutti, Natasa Isailovic, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis
Iulia Szabo, Medeea Badii, Ildikó O. Gaál, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17601-17601
Open Access | Times Cited: 3
Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives
Argyro Vraka, Eleni Diamanti, Mithum Kularatne, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4349-4349
Open Access | Times Cited: 2
Additional file 1 of Protein profiling in systemic sclerosis patients with different pulmonary complications using proteomic antibody microarray
Jing Huang, Honglin Zhu, Sijia Liu, et al.
Figshare (2024)
Open Access
Recent developments in connective tissue disease associated pulmonary arterial hypertension
Stefano Rodolfi, Voon H Ong, Christopher P. Denton
International Journal of Cardiology Congenital Heart Disease (2024) Vol. 16, pp. 100513-100513
Open Access
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions
Salaheldin Ahmed, Abdulla Ahmed, Göran Rådegran
JHLT Open (2024) Vol. 6, pp. 100152-100152
Open Access
Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review
Anna Bazsó, Péter Szodoray, Yehuda Shoenfeld, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 10, pp. 3055-3072
Open Access
Ten clinical conundrums in the management of eosinophilic granulomatosis with polyangiitis
Íñigo Rúa‐Figueroa, Roser Soláns-Laqué, Marina Blanco–Aparicio, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access
Proteomic Biomarkers for Survival in Systemic Sclerosis-associated Pulmonary Hypertension
V. Mismetti, Xavier Delavenne, David Montani, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Protein profiling in systemic sclerosis patients with different pulmonary complications using proteomic antibody microarray
Jing Huang, Honglin Zhu, Sijia Liu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Novel role of vascular chemerin in blood vessel tone
Ruinan Hu, David A. Bulger, Kathy K. Griendling
AJP Heart and Circulatory Physiology (2023) Vol. 325, Iss. 2, pp. H321-H322
Closed Access
Systemic Sclerosis - Recent Advances and New Perspectives [Working Title]

IntechOpen eBooks (2023)
Closed Access
Assessment of Lung Involvement and Prognostic Value of thе 6-Minute Walking Test for Pulmonary Involvement in Patients with Systemic Sclerosis
Mariela Geneva‐Popova, Stanislava Popova‐Belova, Sanie Dzambasova, et al.
IntechOpen eBooks (2023)
Open Access
Causal relationship between circulating cytokines and the risk of systemic sclerosis: A bidirectional Mendelian-randomization study
Hua Song, Jinxin Zheng, Shunzi Shao, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top